Navegar por autor "Lavilla Rubira, Esperanza"

Mostrando ítems 1-8 de 8

A personalized medicine ex vivo test to predict clinical response to first line induction therapy with idarubicin and cytarabine in patients with acute myeloid leukemia

2013- Lavilla Rubira, Esperanza
Ex vivo pharmacological evaluation of 16 drugs in 60+ acute myeloid leukemia patients using whole bone marrow samples analyzed by automated flow cytometry

2013- Lavilla Rubira, Esperanza
High correlation between clinical responses to 1st line AML patients treated with cytarabine and idarubicin and their pharmacological profiles in patient samples measured by exvitech

2014- Lavilla Rubira, Esperanza
Personalizing therapies with ex vivo pharmacological responses may uncover the differences between IDA-DNR-MIT among european AML protocols

2013- Lavilla Rubira, Esperanza
Pharmacological profile of cytarabine and idarubicin in patient samples (ex vivo) with newly diagnosed acute myeloid leukemia identifies responders vs non responders

2013- Lavilla Rubira, Esperanza
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine

2014- Lavilla Rubira, Esperanza
Pharmacological profiles of AML treatments in patient samples to personalize treatment.

2014- Fernandez Fernandez, Angeles; Lavilla Rubira, Esperanza
Population pharmacological profiles of aml treatments in patient samples by automated flow cytometry; a bridge to individualized medicine

2013- Lavilla Rubira, Esperanza